Controlled induction of human pancreatic progenitors produces functional beta‐like cells in vitro
Russ, Holger A; Parent, Audrey V; Ringler, Jennifer J; Hennings, Thomas G; Nair, Gopika G; Shveygert, Mayya; Guo, Tingxia; Puri, Sapna; Haataja, Leena; Cirulli, Vincenzo; Blelloch, Robert; Szot, Greg L; Arvan, Peter; Hebrok, Matthias
2015-07-02
View/ Open
Citation
Russ, Holger A; Parent, Audrey V; Ringler, Jennifer J; Hennings, Thomas G; Nair, Gopika G; Shveygert, Mayya; Guo, Tingxia; Puri, Sapna; Haataja, Leena; Cirulli, Vincenzo; Blelloch, Robert; Szot, Greg L; Arvan, Peter; Hebrok, Matthias (2015). "Controlled induction of human pancreatic progenitors produces functional beta‐like cells in vitro." The EMBO Journal 34(13): 1759-1772.
Abstract
Directed differentiation of human pluripotent stem cells into functional insulin‐producing beta‐like cells holds great promise for cell replacement therapy for patients suffering from diabetes. This approach also offers the unique opportunity to study otherwise inaccessible aspects of human beta cell development and function in vitro. Here, we show that current pancreatic progenitor differentiation protocols promote precocious endocrine commitment, ultimately resulting in the generation of non‐functional polyhormonal cells. Omission of commonly used BMP inhibitors during pancreatic specification prevents precocious endocrine formation while treatment with retinoic acid followed by combined EGF/KGF efficiently generates both PDX1+ and subsequent PDX1+/NKX6.1+ pancreatic progenitor populations, respectively. Precise temporal activation of endocrine differentiation in PDX1+/NKX6.1+ progenitors produces glucose‐responsive beta‐like cells in vitro that exhibit key features of bona fide human beta cells, remain functional after short‐term transplantation, and reduce blood glucose levels in diabetic mice. Thus, our simplified and scalable system accurately recapitulates key steps of human pancreas development and provides a fast and reproducible supply of functional human beta‐like cells.SynopsisFocusing on developmental mechanisms, the results of this study further accelerate successful differentiation of human ESCs into functional pancreatic beta cells.Exclusion of commonly used BMP inhibitors during human embryonic stem cell to pancreatic progenitor differentiation prevents precocious endocrine induction.Sequential exposure of foregut cells to retinoic acid followed by combined EGF/KGF treatment establishes highly pure PDX1+ and PDX1+/NKX6.1+ progenitor populations, respectively.Precise temporal induction of endocrine differentiation in PDX1+/NKX6.1+ progenitors, but not in PDX1+/NKX6.1− progenitors, results in the generation of functional beta‐like cells in vitro.Beta‐like cells exhibit key features of bona fide human beta cells, remain functional after short‐term transplantation, and reduce blood glucose levels in diabetic mice.Focusing on developmental mechanisms, the results of this study further accelerate successful differentiation of human ESCs into functional pancreatic beta cells.Publisher
Wiley Periodicals, Inc. Artech House
ISSN
0261-4189 1460-2075
Other DOIs
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.